Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Nguyen

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The American Journal of Surgical Pathology|December 19, 2019
"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct EntityRajal B Shah, Bradley A Stohr, Zheng Jin Tu, et al.
Urologic Oncology|June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancerRebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The American Journal of Surgical Pathology|December 19, 2019
"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct EntityRajal B Shah, Bradley A Stohr, Zheng Jin Tu, et al.
Urologic Oncology|June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancerRebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Pageof 3